Nutra Pharma Corp (NPHC) Invested Capital (2010 - 2026)

Nutra Pharma has disclosed Invested Capital across 17 years of filings, most recently posting -$19.0 million for Q2 2026.

• In Q2 2026, Invested Capital fell 250.94% year-over-year to -$19.0 million; the TTM figure through Jun 2026 stood at -$19.0 million (down 250.94% YoY), while the FY2025 annual figure was -$6.1 million, down 11.62% from the prior year.
• Invested Capital came in at -$19.0 million for Q2 2026 at Nutra Pharma, down from -$16.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $4.0 million in Q1 2023 to a low of -$19.0 million in Q2 2026.
• Average Invested Capital over 5 years is -$3.0 million, with a median of -$1.9 million recorded in 2022.
• Year-over-year, Invested Capital jumped 427.31% in 2023 and tumbled 286.0% in 2025.
• Over 5 years, Invested Capital stood at -$2.5 million in 2022, then surged by 248.63% to $3.7 million in 2023, then tumbled by 248.13% to -$5.5 million in 2024, then retreated by 11.62% to -$6.1 million in 2025, then slumped by 211.79% to -$19.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were -$19.0 million in Q2 2026, -$16.0 million in Q1 2026, and -$6.1 million in Q4 2025.